John P Bilezikian Selected Research

Osteoporosis

1/2022	Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases.
12/2021	Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?
1/2021	Bone Mineral Density: Clinical Relevance and Quantitative Assessment.
11/2020	Report on the Audit on Burden of Osteoporosis in Eight Countries of the Eurasian Region: Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan.
11/2020	Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.
8/2020	Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
1/2020	Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases.
12/2019	Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial.
1/2019	Osteoanabolic and dual action drugs.
1/2019	Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John P Bilezikian Research Topics

Disease

90	Osteoporosis 01/2022 - 03/2002
39	Hypoparathyroidism 01/2022 - 09/2006
38	Primary Hyperparathyroidism 03/2022 - 10/2003
15	Hypercalcemia (Milk Alkali Syndrome) 10/2021 - 11/2005
15	Bone Resorption 01/2019 - 06/2002
13	Postmenopausal Osteoporosis 08/2020 - 09/2003
11	Metabolic Bone Diseases (Osteopenia) 12/2020 - 09/2003
10	Hypocalcemia 09/2021 - 06/2012
8	Neoplasms (Cancer) 01/2020 - 01/2004
6	Hypercalciuria 01/2020 - 03/2007
6	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2012
6	Hyperparathyroidism 10/2014 - 11/2003
5	Nephrolithiasis 01/2022 - 03/2014
5	Vitamin D Deficiency 12/2020 - 01/2013
4	Osteoporotic Fractures 11/2020 - 02/2009
4	Bone Diseases (Bone Disease) 01/2020 - 01/2016
4	Parathyroid Neoplasms (Parathyroid Neoplasm) 06/2011 - 10/2003
3	COVID-19 12/2021 - 11/2020
3	Hyperphosphatemia 01/2020 - 06/2016
3	Deficiency Diseases (Deficiency Disease) 01/2015 - 06/2012
3	Osteonecrosis (Kienbock's Disease) 02/2011 - 11/2006
3	Premenstrual Syndrome (Premenstrual Tension) 05/2008 - 08/2007
3	Premenstrual Dysphoric Disorder 05/2008 - 08/2007
2	Hypophosphatemia 01/2022 - 01/2020
2	Obesity 12/2021 - 01/2018
2	Diabetes Mellitus 12/2021 - 11/2014
2	Rickets (Rachitis) 12/2020 - 10/2018
2	Parathyroid Diseases (Parathyroid Disorders) 09/2020 - 12/2011
2	Kidney Calculi (Kidney Stone) 01/2018 - 01/2017
2	Nephrocalcinosis 01/2017 - 07/2014
2	Bone Fractures (Bone Fracture) 01/2016 - 09/2008
2	Body Weight (Weight, Body) 01/2016 - 12/2011
2	Esophageal Neoplasms (Esophageal Cancer) 07/2012 - 04/2009
2	Epilepsy (Aura) 04/2007 - 12/2004
1	Constipation 01/2022
1	Sunburn 01/2022
1	Hypophosphatasia 01/2022
1	Periprosthetic Fractures 01/2022
1	Malabsorption Syndromes (Malabsorption Syndrome) 12/2021
1	Hepatic Insufficiency 12/2021
1	Multiple Fractures 01/2021

Drug/Important Bio-Agent (IBA)

66	Parathyroid Hormone (Parathormone)IBA 09/2021 - 05/2002
49	CalciumIBA 01/2022 - 08/2003
28	Vitamin D FDA LinkGeneric 01/2022 - 08/2003
21	Diphosphonates (Bisphosphonates)IBA 01/2021 - 09/2003
21	Teriparatide (Parathar)FDA Link 12/2019 - 03/2004
15	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2020 - 06/2002
13	GlucocorticoidsIBA 12/2021 - 05/2002
9	Bone Density Conservation AgentsIBA 09/2011 - 03/2002
8	Pharmaceutical PreparationsIBA 01/2018 - 12/2004
8	MineralsIBA 01/2017 - 01/2006
7	Hormones (Hormone)IBA 06/2016 - 10/2003
6	1,25-dihydroxyvitamin DIBA 01/2020 - 11/2005
5	abaloparatideIBA 11/2020 - 02/2017
5	Parathyroid Hormone-Related ProteinIBA 01/2020 - 10/2002
5	AlbuminsIBA 12/2019 - 07/2013
5	Insulin (Novolin)FDA Link 12/2016 - 08/2006
5	Growth Hormone (Somatotropin)IBA 12/2016 - 07/2002
4	Cinacalcet (Sensipar)FDA Link 01/2022 - 12/2003
4	romosozumabIBA 08/2020 - 05/2014
4	Estrogens (Estrogen)FDA Link 01/2020 - 05/2002
4	Anabolic AgentsIBA 01/2020 - 03/2003
4	Insulin-Like Growth Factor I (IGF-1)IBA 12/2016 - 07/2002
4	Collagen Type I (Type I Collagen)IBA 01/2016 - 09/2008
3	Denosumab FDA Link 01/2021 - 01/2013
3	25-hydroxyvitamin DIBA 01/2021 - 02/2011
3	CanagliflozinIBA 01/2018 - 01/2016
3	Phosphates (Orthophosphate)IBA 04/2017 - 01/2017
3	OsteocalcinIBA 01/2016 - 05/2008
3	Risedronic Acid (Actonel)FDA LinkGeneric 08/2013 - 10/2008
2	SaltsIBA 01/2022 - 07/2014
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2020 - 01/2016
2	IodineIBA 10/2019 - 06/2016
2	Biological ProductsIBA 01/2019 - 08/2007
2	hydroxide ionIBA 10/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2011
2	Sodium-Glucose Transport ProteinsIBA 01/2016 - 01/2016
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2016 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2011
2	AndrogensIBA 11/2014 - 02/2009
2	Rosiglitazone (Avandia)FDA Link 04/2013 - 01/2012
2	AntibodiesIBA 03/2013 - 03/2012
2	Cathepsin KIBA 01/2013 - 06/2011
2	collagen type I trimeric cross-linked peptideIBA 12/2011 - 05/2008
2	Tetracycline (Achromycin)FDA LinkGeneric 09/2010 - 12/2008
2	SteroidsIBA 01/2008 - 01/2004
2	Anticonvulsants (Antiepileptic Drugs)IBA 04/2007 - 12/2004
2	strontium ranelate (protelos)IBA 08/2006 - 01/2006
1	Calcium Carbonate (Limestone)FDA Link 01/2022
1	Calcium CitrateIBA 01/2022
1	serum P-component (CIt)IBA 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	OxalatesIBA 01/2022
1	Cholecalciferol (Vitamin D3)FDA Link 12/2021

Therapy/Procedure

72	Therapeutics 01/2022 - 05/2002
11	Parathyroidectomy 03/2022 - 10/2003
2	Bariatric Surgery 12/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2004
2	Radiotherapy 06/2016 - 01/2004
2	Thyroidectomy 01/2016 - 11/2013